Merck KGaA (MRK) - Medical Equipment - Deals and Alliances Profile

Date: April 24, 2018
Pages: 114
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: ME17762A6D9EN
Leaflet:

Download PDF Leaflet

Merck KGaA (MRK) - Medical Equipment - Deals and Alliances Profile
Summary

Merck KGaA (Merck), a subsidiary of E. Merck KG, is a pharmaceutical and chemical company. It discovers, develops and manufactures prescription drugs to treat cancer, multiple sclerosis, and infertility and over-the-counter products for colds and pain; and develops liquid crystal mixtures, OLED materials and cosmetic active ingredients. The company also provides a wide range of products including lab water systems to gene editing tools, cell lines, antibodies and end-to-end systems. Merck serves healthcare, performance materials and life sciences markets. It has presence in Europe, North America, Asia-Pacific, Latin America and Middle East and Africa. Merck is headquartered in Darmstadt, Hesse, Germany.

Merck KGaA (MRK) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.

NOTE: Out of security concerns GlobalData requires using corporate email address.
Merck KGaA, Medical Equipment, Deals By Year, 2012 to YTD 2018
Merck KGaA, Medical Equipment Deals By Type, 2012 to YTD 2018
Merck KGaA, Medical Equipment, Deals By Region, 2012 to YTD 2018
Merck KGaA, Medical Equipment, Deals By Market, 2012 to YTD 2018
Merck KGaA, Medical Equipment, Deals Summary, 2012 to YTD 2018
Merck KGaA, Medical Equipment, Deal Details
Asset Purchase
Sigma-Aldrich Acquires Duolink Product Portfolio from Olink Bioscience
BioReliance To Acquire Rights To Big Blue Colonies and Cell Lines From Agilent Technologies
Venture Financing
DNA Script Raises USD13.2 Million in Series A Financing
SerImmune Raises USD8 Million in Venture Financing
Partnerships
Sysmex Enters Into Licensing Agreement With Merck Millipore
MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test
HTG Molecular Diagnostics Enters into Agreement with Merck
Exosome Diagnostics Enters into Agreement with Merck
BioMed X Enters into Agreement with Merck
HTG Molecular Diagnostics Enters into Agreement with Merck
R-Biopharm Enters into Agreement with Merck
Emulate Expands Research Agreement with Merck
Merck and Pfizer Enters into Agreement with Dako
Sigma-Aldrich Enters into Distribution Agreement with LGC
Sigma-Aldrich and GenapSys to Co-Market Genius system
Merck Serono Enters into Co- Development Agreement with Illumina
Abcam Enters into Co-Marketing Agreement with Cell Marque for IVD IHC RabMAb Antibodies
Ventana Medical Systems Enters into Co-Development Agreement with Merck Serono for Companion Diagnostic Test
True Diagnostics Enters into Co-Marketing Agreement With Merck
Sigma-Aldrich Enters Into Distribution Agreement With Biomatrica For Biospecimen Storage Products
Firefly BioWorks Enters Into Distribution Agreement With EMD Millipore
Life Technologies Enters Into Agreement With Merck Serono To Develop And Commercialize Companion Diagnostics
Gyros And EMD Millipore Enter Into Agreement To Develop And Commercialize Immunoassay Kits
Luminex Extends Distribution Agreement With EMD Millipore
Alchemia Enters Into Collaboration Agreement with Merck Serono
GE Healthcare Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich
Sigma Life Science Enters Into Distribution Agreement With Olink Bioscience For Duolink Technology
EMD Millipore Enters Into Co-Development Agreement With Sistemic For Stem Cell Markers
Merck Serono Enters Into Co-Development Agreement With Auxogyn For Early Embryo Viability Assessment Test
Sage Labs Enters Into Agreement With Ekam Imaging To Develop Imaging Assays
SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor
Little Things Factory Enters Into Distribution Agreement With Sigma-Aldrich For Microreactors
Mendor Enters Into Distribution Agreement With Merck Serono
Merck Extends Licensing Agreement with Progyny
Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents
Cyprotex Enters Into Licensing Agreement With Sigma For Zinc Finger Nuclease Technology
Equity Offering
KalVista Pharma Raises USD9.1 Million in Private Placement of Shares
Debt Offering
Merck Raises USD916 Million in Private Placement of 0.75% Bonds Due 2019
Merck Raises USD801.4 Million in Private Placement of 0.23% Bonds Due 2017
Merck Raises USD629.7 Million in Private Placement of 1.375% Bonds Due 2022
Asset Transactions
Zydus Healthcare Acquires Six Brands from Merck
Honeywell International Acquires Research Chemicals Business from Sigma-Aldrich
Acquisition
Merck to Acquire Natrix Separations
Merck Acquires Sigma-Aldrich for USD17 Billion
Sigma-Aldrich Acquires Cell Marque
Proxy Labs Acquires MicroSafe Laboratories From Millipore
Merck KGaA - Key Competitors
Merck KGaA - Key Employees
Merck KGaA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Strategy And Business Planning
Sep 28, 2017: Merck On Course To Achieve Objectives for 2018
Sep 05, 2017: Merck Prepares Strategic Options for the Consumer Health Business
Jul 21, 2017: Merck Opens New Application Laboratory in Shanghai
Jun 29, 2017: Merck Expands Packaging Capacity at Swiss Biotech Manufacturing Site of Aubonne
Jun 20, 2017: Merck Ventures Creates New Immuno-Oncology Company iOnctura
May 16, 2017: Merck: Optimizing the Further Development of the Darmstadt Site
Apr 20, 2017: Merck Provides Upgraded Manufacturing Capabilities to BioInvent with Single-use Mobius Bioreactors
Jan 17, 2017: Merck Opens Production Facility Exclusively for Meglumine in Spain
Financial Announcements
Feb 02, 2018: Merck Announces Fourth-Quarter and Full-Year 2017 Financial Results
Nov 09, 2017: Merck Confirms Outlook for 2017 Despite a Challenging Third Quarter
Aug 03, 2017: Q2 2017: Merck Sets Course for Future Growth
May 18, 2017: Merck Continues to Grow Profitably in the First Quarter
Corporate Communications
Jan 26, 2018: Merck Appoints Dirk Toepfer as Chief Information Officer
Dec 15, 2017: Petra Wicklandt Appointed Head of Corporate Affairs at Merck
Dec 12, 2017: Allan Gabor Takes Over the Leadership of Merck in China
Dec 06, 2017: Merck: Resignation of Managing Director
Sep 11, 2017: Merck Names Heidi Fagerholm as New Head of Advanced Technologies
Aug 03, 2017: Executive Board Changes at Merck
Jul 21, 2017: Merck Opens New Application Laboratory in Shanghai
May 12, 2017: Constantin Birnstiel to Become Head of Group Communications at Merck
Feb 08, 2017: North American Businesses of Merck Certified as 2017 Top Employer
Product News
Apr 04, 2018: MilliporeSigma to Launch New Flow Cytometer, Host CellStream Workshop at CYTO 2018
Other Significant Developments
Apr 05, 2018: Merck and Schneider Electric Sign MoU to Advance China’s Biopharmaceutical Industry
Feb 21, 2018: Merck Invests Additional €40 Million to Enhance Manufacturing and Distribution in Asia
Jul 12, 2017: Merck Refines Western European Life Science Production Site Network
May 18, 2017: Rational Surgical Solutions integrates Merck Manual of Medicine into Surgery CareSite
Mar 21, 2017: Merck Accelerator Hits New Peak of Applications
Mar 09, 2017: Merck Generates Record Sales and Continues to Grow Profitably in 2016
Jan 12, 2017: Merck and Palantir Launch New Healthcare Acceleration Partnership
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Merck KGaA, Medical Equipment, Key Facts, 2017
Merck KGaA, Medical Equipment, Deals Summary, 2012 to YTD 2018
Merck KGaA, Medical Equipment, Deals By Year, 2012 to YTD 2018
Merck KGaA, Medical Equipment Deals By Type, 2012 to YTD 2018
Merck KGaA, Medical Equipment, Deals By Region, 2012 to YTD 2018
Merck KGaA, Deals By Market, 2012 to YTD 2018
Merck KGaA, Medical Equipment, Deals Summary, 2012 to YTD 2018
Sigma-Aldrich Acquires Duolink Product Portfolio from Olink Bioscience
BioReliance To Acquire Rights To Big Blue Colonies and Cell Lines From Agilent Technologies
DNA Script Raises USD13.2 Million in Series A Financing
SerImmune Raises USD8 Million in Venture Financing
Sysmex Enters Into Licensing Agreement With Merck Millipore
MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test
HTG Molecular Diagnostics Enters into Agreement with Merck
Exosome Diagnostics Enters into Agreement with Merck
BioMed X Enters into Agreement with Merck
HTG Molecular Diagnostics Enters into Agreement with Merck
R-Biopharm Enters into Agreement with Merck
Emulate Expands Research Agreement with Merck
Merck and Pfizer Enters into Agreement with Dako
Sigma-Aldrich Enters into Distribution Agreement with LGC
Sigma-Aldrich and GenapSys to Co-Market Genius system
Merck Serono Enters into Co- Development Agreement with Illumina
Abcam Enters into Co-Marketing Agreement with Cell Marque for IVD IHC RabMAb Antibodies
Ventana Medical Systems Enters into Co-Development Agreement with Merck Serono for Companion Diagnostic Test
True Diagnostics Enters into Co-Marketing Agreement With Merck
Sigma-Aldrich Enters Into Distribution Agreement With Biomatrica For Biospecimen Storage Products
Firefly BioWorks Enters Into Distribution Agreement With EMD Millipore
Life Technologies Enters Into Agreement With Merck Serono To Develop And Commercialize Companion Diagnostics
Gyros And EMD Millipore Enter Into Agreement To Develop And Commercialize Immunoassay Kits
Luminex Extends Distribution Agreement With EMD Millipore
Alchemia Enters Into Collaboration Agreement with Merck Serono
GE Healthcare Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich
Sigma Life Science Enters Into Distribution Agreement With Olink Bioscience For Duolink Technology
EMD Millipore Enters Into Co-Development Agreement With Sistemic For Stem Cell Markers
Merck Serono Enters Into Co-Development Agreement With Auxogyn For Early Embryo Viability Assessment Test
Sage Labs Enters Into Agreement With Ekam Imaging To Develop Imaging Assays
SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor
Little Things Factory Enters Into Distribution Agreement With Sigma-Aldrich For Microreactors
Mendor Enters Into Distribution Agreement With Merck Serono
Merck Extends Licensing Agreement with Progyny
Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents
Cyprotex Enters Into Licensing Agreement With Sigma For Zinc Finger Nuclease Technology
KalVista Pharma Raises USD9.1 Million in Private Placement of Shares
Merck Raises USD916 Million in Private Placement of 0.75% Bonds Due 2019
Merck Raises USD801.4 Million in Private Placement of 0.23% Bonds Due 2017
Merck Raises USD629.7 Million in Private Placement of 1.375% Bonds Due 2022
Zydus Healthcare Acquires Six Brands from Merck
Honeywell International Acquires Research Chemicals Business from Sigma-Aldrich
Merck to Acquire Natrix Separations
Merck Acquires Sigma-Aldrich for USD17 Billion
Sigma-Aldrich Acquires Cell Marque
Proxy Labs Acquires MicroSafe Laboratories From Millipore
Merck KGaA, Key Competitors
Merck KGaA, Key Employees
Merck KGaA, Subsidiaries

LIST OF FIGURES

Merck KGaA, Medical Equipment, Deals by Type, 2012 to YTD 2018
Merck KGaA, Medical Equipment, Deals By Year, 2012 to YTD 2018
Merck KGaA, Medical Equipment, Deals By Region, 2012 to YTD 2018
Merck KGaA, Medical Equipment, Deals By Market, 2012 to YTD 2018
Merck KGaA, Medical Equipment, Deals By Year, 2012 to YTD 2018
Merck KGaA, Medical Equipment, Deals by Type, 2012 to YTD 2018
Merck KGaA, Medical Equipment, Deals By Region, 2012 to YTD 2018
Merck KGaA, Medical Equipment, Deals by Market, 2012 to YTD 2018
Skip to top


Ask Your Question

Merck KGaA (MRK) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: